Rituximab for the treatment of type II mixed cryoglobulinemia
β Scribed by Francesco Zaja; Salvatore De Vita; Domenico Russo; Angela Michelutti; Renato Fanin; Gianfranco Ferraccioli; Michele Baccarani
- Publisher
- John Wiley and Sons
- Year
- 2002
- Tongue
- English
- Weight
- 466 KB
- Volume
- 46
- Category
- Article
- ISSN
- 0004-3591
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
Recurrent transfusion-related acute lung injury after fresh frozen plasma in a patient with hereditary factor V deficiency To the Editor: Transfusion-related acute lung injury (TRALI) can be a serious complication resulting from the transfusion of plasma that contains antibodies against recipient w
The mixed state of type II superconductor was studied by means of the Wigner-Seitz approximation at j ) 1 for the entire range of magnetic fields between H c1 `H0 `Hc2 . The vortex structure was described in the framework of the improved London model with finite core radius by the introduction of th
## Abstract ## Objective Juvenile dermatomyositis (DM) is a chronic inflammatory myopathy of childhood primarily affecting the muscles and skin. Treatment for juvenile DM is often difficult, and conventional therapies include corticosteroids and other immune suppressants. We reviewed the records o
## Abstract ## Objective To conduct a longβterm, prospective, randomized controlled trial evaluating rituximab (RTX) therapy for severe mixed cryoglobulinemia or cryoglobulinemic vasculitis (CV). ## Methods Fiftyβnine patients with CV and related skin ulcers, active glomerulonephritis, or refrac